IceCure (ICCM) CFO Peleg Meir Receives RSU Award

What Happened
Peleg Meir, Chief Financial Officer of IceCure Medical Ltd. (ICCM), received an award of 181,483 restricted share units (RSUs) on August 14, 2026. The RSUs were granted at $0 per share (typical for RSU awards) and remain unvested. A previously granted tranche of 13,333 RSUs (granted May 17, 2026) is also disclosed and has been adjusted for the issuer’s 1-for-30 reverse share split; together the filing references 194,816 unvested RSUs in total.

Key Details

• Transaction type: Award/Grant (Code A).
• Transaction date: August 14, 2026; filing date: August 17, 2026.
• Shares awarded: 181,483 RSUs (new grant). Price per share reported: $0.
• Previously granted: 13,333 RSUs (May 17, 2026), adjusted for 1-for-30 reverse split.
• Total unvested RSUs disclosed: 194,816 (181,483 + 13,333).
• Vesting schedule (new grant): 25% vests on Aug 11, 2027; remaining 75% vests in twelve equal quarterly installments of 6.25% thereafter. (The May 17 grant vests 25% on May 17, 2027, then 75% in twelve equal quarterly installments.)
• Shares owned after transaction: the Form 4 does not state total common-stock holdings; it discloses the unvested RSUs above.
• Filing timeliness: Form filed Aug 17, 2026. No late filing is indicated in the document.

Context
RSUs are time‑based equity awards that convert into shares only as they vest; they do not involve an immediate cash purchase or sale. Because these RSUs are unvested, they do not reflect an immediate change in share ownership or an executed market trade. The May 17 grant figure shown has been reduced to reflect IceCure’s 1-for-30 reverse share split effective June 4, 2026.